Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > American Chemical Society's highest honor goes to pioneer of controlled-release drugs

Abstract:
Robert S. Langer, Sc.D., the David H. Koch Institute Professor at Massachusetts Institute of Technology, has been named winner of the 2012 Priestley Medal by the American Chemical Society (ACS).

American Chemical Society's highest honor goes to pioneer of controlled-release drugs

Washington, DC | Posted on August 18th, 2011

The award recognizes Langer's cutting-edge research that helped launch the controlled-release drug industry and the field of tissue engineering. His work cuts across disciplines to deliver advances in pharmaceuticals, chemical engineering and medical devices from the laboratory to patients. The annual award, the highest honor bestowed by ACS, consists of a gold medallion designed to commemorate the work of Joseph Priestley, as well as a presentation box and a certificate. One of the founders of modern chemistry, Priestley is perhaps best known for his discovery of oxygen in 1774. The award was presented at the 242nd National Meeting & Exposition of the ACS, which is taking place here this week.

"Professor Langer is a talented scientist who is motivated by a sense of responsibility to help people," says longtime collaborator Joseph P. Vacanti, M.D., a tissue engineering expert and pediatric surgeon at MassGeneral Hospital for Children. "His pioneering work, in particular in slow-release medicines, has helped millions of people throughout the world."

Langer pioneered the field of slow-release medicines, which provide consistent amounts of a drug over a long period, reducing the number of pills that a patient has to take. In one of his first discoveries, Langer found that certain materials could be dissolved, mixed with large molecular weight drugs and formed into new materials that slowly release these drugs into the body.

Another contribution was to revolutionize the way that biomedical devices are developed. Before Langer's group became involved in this line of research, clinicians would typically take off-the-shelf materials that somewhat looked or functioned like the tissue or organ they were studying and modify them. Langer took a different approach and used chemistry and chemical engineering concepts to design the biomaterials they needed.

A third key contribution was helping start the field of regenerative medicine and tissue engineering to address the problem of donor-organ shortages. More than 100,000 people in the United States are currently awaiting organ transplants, and many die while on the waiting list. Langer and colleagues created degradable polymer scaffolds on which human cells could grow. This innovation led to artificial skin, muscles, nerves, cartilage, bone and organs that are now used to treat patients.

Most recently, Langer's team developed contact lenses that release drugs and a gel that can help people with damaged vocal cords regain their voices. His group also is branching out into development of new surfaces on which stem cells can grow and novel ways using nanotechnology to deliver short interfering RNAs that could turn off malfunctioning genes that cause disease.

Langer runs one of the largest academic laboratories in the world, with nearly 100 members. He is an author of more than 1,100 research papers and has 800 issued and pending patents that have been licensed or sublicensed to more than 220 companies. He has also been involved in the creation of 25 companies.

The Priestley Medal is an annual award named for Joseph Priestley, who reported the discovery of oxygen in 1774. Since 1923, the ACS has recognized groundbreaking chemists with the award.

####

About American Chemical Society (ACS)
The American Chemical Society is a non-profit organization chartered by the U.S. Congress. With more than 163,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society contact .

For more information, please click here

Contacts:
Michael Bernstein

303-228-8532 (Aug. 25-Sept. 1)
202-872-6042 (Before Aug. 25)

Michael Woods

303-228-8532 (Aug. 25-Sept. 1)
202-872-6293 (Before Aug. 25)

Copyright © American Chemical Society

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

Chemistry

Ultra-efficient removal of carbon monoxide using gold nanoparticles on a molecular support: New method and mechanism for state-of-the-art gas purification February 9th, 2018

Fast-spinning spheres show nanoscale systems' secrets: Rice University lab demonstrates energetic properties of colloids in spinning magnetic field February 7th, 2018

New filters could enable manufacturers to perform highly-selective chemical separation January 23rd, 2018

Nanowrinkles could save billions in shipping and aquaculture Surfaces inspired by carnivorous plants delay degradation by marine fouling January 17th, 2018

Nanomedicine

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers February 15th, 2018

Understanding brain functions using upconversion nanoparticles: Researchers can now send light deep into the brain to study neural activities February 14th, 2018

Announcements

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

Rutgers-Led Innovation Could Spur Faster, Cheaper, Nano-Based Manufacturing: Scalable and cost-effective manufacturing of thin film devices February 14th, 2018

Joseph N. Pelton named 2017 Lifeboat Foundation Guardian Award Winner February 1st, 2018

Silk fibers could be high-tech ‘natural metamaterials’ January 31st, 2018

A simple new approach to plastic solar cells: Osaka University researchers intelligently design new highly efficient organic solar cells based on amorphous electronic materials with potential for easy printing January 28th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project